{"id":217258,"date":"2023-06-26T11:00:00","date_gmt":"2023-06-26T11:00:00","guid":{"rendered":"https:\/\/bm.dev.synology.me\/?p=217258"},"modified":"2023-06-26T11:00:00","modified_gmt":"2023-06-26T11:00:00","slug":"pionierat-in-oftalmologie","status":"publish","type":"post","link":"https:\/\/bm.dev.synology.me\/?p=217258","title":{"rendered":"Pionierat \u00een oftalmologie"},"content":{"rendered":"<p>\n<strong>Cu peste 140 de ani de inova\u0163ie pe pia\u0163a interna\u0163ional\u0103 de oftalmologie, Compania Farmaceutic\u0103 Th\u00e9a, Fondat\u0103 de familia Chibret, \u00ee\u015fi continu\u0103 pionieratul, din 2008 \u015fi \u00een Rom\u00e2nia, folosindu-se de dou\u0103 resurse pre\u0163ioase: cea uman\u0103 \u015fi cea tehnologic\u0103. Ce datorie \u015fi-a asumat, ca lider al pie\u0163ei locale, fa\u0163\u0103 de pacien\u0163i \u015fi ceilal\u0163i juc\u0103tori din industrie?<\/strong><\/p>\n<p>\n&nbsp;<\/p>\n<p>\n<img decoding=\"async\" alt=\"\" src=\"http:\/\/storage0.dms.mpinteractiv.ro\/media\/401\/341\/5531\/21966364\/2\/09-cifre-advertorial.jpg?height=614&#038;width=150\" style=\"width: 150px; height: 614px; margin: 10px; float: right;\" \/>\u201eC\u00e2nd e\u015fti lider \u00eentr-o pia\u0163\u0103, \u00een general toate luminile reflectoarelor sunt pe tine. Ceilal\u0163i juc\u0103tori, de cele mai multe ori, caut\u0103 s\u0103 \u00ee\u0163i analizeze ac\u0163iunile, pe unele s\u0103 le copieze, dorindu-\u015fi s\u0103 g\u0103seasc\u0103 c\u00e2t mai rapid calea care pe tine te-a propulsat pe primul loc\u201d, spune Radu Tudor, director general al Th\u00e9a Pharma Rom\u00e2nia. Odat\u0103 ajuns lider, adaug\u0103 el, ai o mare datorie moral\u0103. Fa\u0163\u0103 de pacien\u0163i, de medici \u015fi fa\u0163\u0103 de ceilal\u0163i juc\u0103tori, a\u015fa c\u0103 trebuie s\u0103 te asiguri c\u0103 valorile tale morale sunt extrem de s\u0103n\u0103toase. \u201eCa lider, po\u0163i impune un trend \u00een pia\u0163a respectiv\u0103 \u015fi trebuie s\u0103 te asiguri c\u0103 ceea ce impui este valoros din punct de vedere moral. Dac\u0103 se \u015ftie c\u0103 la Th\u00e9a oamenii sunt pre\u0163ui\u0163i, produsele au cea mai \u00eenalt\u0103 calitate, c\u0103 se investe\u015fte \u00een educa\u0163ia \u015ftiin\u0163ific\u0103 a tinerilor oftalmologi sau \u00een diverse ac\u0163iuni de CSR, toate acestea vor fi replicate \u00eentr-o mai mic\u0103 sau mai mare m\u0103sur\u0103 de ceilal\u0163i juc\u0103tori. C\u00e2nd e\u015fti lider, po\u0163i fi asimilat unui p\u0103rinte: nu po\u0163i insufla o anumit\u0103 conduit\u0103 dac\u0103 tu \u00eensu\u0163i nu o adop\u0163i.\u201d<\/p>\n<p>\nDespre atuurile care au contribuit la pozi\u0163ionarea companiei \u00een topul juc\u0103torilor din pia\u0163a local\u0103 de oftalmologie, Radu Tudor spune c\u0103 sunt foarte multe aspecte de luat \u00een considerare, \u201e\u00eens\u0103, dac\u0103 ar fi s\u0103 m\u0103 g\u00e2ndesc la cele mai importante, a\u015f men\u0163iona spiritul antreprenorial, dorin\u0163a de a inova, parteneriatul dezvoltat de-a lungul anilor cu oftalmologii \u015fi pacien\u0163ii, \u015fi nu \u00een ultimul r\u00e2nd, maniera \u00een care oamenii sunt pre\u0163ui\u0163i \u015fi valoriza\u0163i \u00een cadrul companiei noastre\u201d.<\/p>\n<p>\n&nbsp;Pentru a reu\u015fi s\u0103 inoveze \u00een continuare, compania se folose\u015fte tot mai mult \u015fi de noile tehnologii. \u201eUtiliz\u0103m din ce \u00een ce mai multe programe care se folosesc de inteligen\u0163a artificial\u0103, \u00een special programe tip business intelligence. Inteligen\u0163a artificial\u0103 ne ajut\u0103 s\u0103 facem diverse analize, din ce \u00een ce mai complexe, \u015fi s\u0103 elimin\u0103m c\u00e2t mai multe dintre activit\u0103\u0163ile repetitive, lipsite de valoare. Recent, am implementat un program care \u00eenva\u0163\u0103 s\u0103 citeasc\u0103&nbsp; anumite documente, s\u0103 extrag\u0103 informa\u0163ii relevante din acestea \u015fi s\u0103 le \u00eenregistreze. Ne economise\u015fte foarte mult timp \u015fi permite colegilor mei s\u0103 dedice acel timp unor ac\u0163iuni mai utile companiei, precum conceperea anumitor strategii. \u015ei da, av\u00e2nd o \u00eenc\u0103rcare mai mic\u0103, s\u0103 fie mai odihni\u0163i \u015fi mai relaxa\u0163i.\u201d P\u00e2n\u0103 \u00een momentul de fa\u0163\u0103, AI-ul i-a demonstrat c\u0103 poate fi un excelent ajutor al speciei noastre \u015fi nu un \u201edistrug\u0103tor\u201d de profesii. \u201eR\u0103m\u00e2ne de v\u0103zut \u00een viitor.\u201d<\/p>\n<p>\nC\u00e2t despre provoc\u0103rile pie\u0163ei,&nbsp; Radu Tudor spune c\u0103, \u201e\u00een prezent, \u00een Rom\u00e2nia, una dintre cele mai mari provoc\u0103ri c\u0103reia trebuie s\u0103 \u00eei facem fa\u0163\u0103 e reprezentat\u0103 de baza limitat\u0103 de selec\u0163ie pe care o avem pentru a ne g\u0103si noi colegi\u201d. Suplimentar provoc\u0103rilor ce \u0163in de resursa uman\u0103, \u00een industria farma, adaug\u0103 el, te love\u015fti de o taxare excesiv\u0103 \u015fi o birocra\u0163ie de-a dreptul obositoare, \u015fi \u201emai trebuie s\u0103 treac\u0103 ceva timp p\u00e2n\u0103 s\u0103 sim\u0163im statul ca pe un partener\u201d. Taxa clawback, continu\u0103 Radu Tudor, dep\u0103\u015fe\u015fte de at\u00e2\u0163ia ani pragul de 30% din pre\u0163ul de produc\u0103tor, iar presiunea exercitat\u0103 de autorit\u0103\u0163i asupra pre\u0163urilor este foarte mare. \u00cen plus, spune el, exist\u0103 o serie de produse pe care compania le are portofoliu \u00een alte \u0163\u0103ri \u015fi pe care nu le pot lansa \u00een Rom\u00e2nia tot din cauza pre\u0163ului impus de minister, tratamente care, chiar dac\u0103 unele au alternative aici, ar fi extrem de utile pacien\u0163ilor, \u201e\u00een special celor cu glaucom. Avem nevoie de o strategie na\u0163ional\u0103 \u015fi \u00een domeniul farmaceutic, ca \u015fi \u00een cazul multor alte domenii, strategie care, din p\u0103cate, se las\u0103 \u00eendelung a\u015fteptat\u0103\u201d.<\/p>\n<p>\nLegat de priorit\u0103\u0163ile companiei pe viitor, \u201epoate c\u0103 v\u0103 a\u015ftepta\u0163i s\u0103 v\u0103 spun c\u0103 una dintre ele este s\u0103 ne men\u0163inem pozi\u0163ia de lider. Pentru noi nu este at\u00e2t de relevant. Mai important este s\u0103 ne asigur\u0103m c\u0103 avem un business s\u0103n\u0103tos \u015fi ne men\u0163inem valorile \u015fi mentalitatea \u00een pofida expansiunii cifrei noastre de afaceri, c\u0103 nu adopt\u0103m abordarea orientat\u0103 exclusiv c\u0103tre profit a anumitor companii listate la burs\u0103, dar \u015fi c\u0103 r\u0103m\u00e2nem aceea\u015fi companie flexibil\u0103 orientat\u0103 c\u0103tre pacient, medic \u015fi echip\u0103. Se va putea discuta oric\u00e2nd la un congres cu domnul Chibret \u015fi vom continua s\u0103 lans\u0103m pe pia\u0163\u0103 acelea\u015fi produse inovative, \u00eenalt calitative. \u00cen plus, vrem s\u0103 r\u0103m\u00e2nem un reper moral \u00een pia\u0163a oftalmologic\u0103\u201d, \u00eencheie Radu Tudor.&nbsp;&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Cu peste 140 de ani de inova\u0163ie pe pia\u0163a interna\u0163ional\u0103 de oftalmologie, Compania Farmaceutic\u0103 Th\u00e9a, Fondat\u0103 de familia Chibret, \u00ee\u015fi continu\u0103 pionieratul, din 2008 \u015fi \u00een Rom\u00e2nia, folosindu-se de dou\u0103 resurse pre\u0163ioase: cea uman\u0103 \u015fi cea tehnologic\u0103. Ce datorie \u015fi-a asumat, ca lider al pie\u0163ei locale, fa\u0163\u0103 de pacien\u0163i \u015fi ceilal\u0163i juc\u0103tori din industrie? &nbsp; [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[510,512],"tags":[24582,408,55046],"class_list":["post-217258","post","type-post","status-publish","format-standard","hentry","category-actualitate","category-revista-bm","tag-advertorial","tag-pacienti","tag-pionierat-in-oftalmologie"],"_links":{"self":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/217258","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=217258"}],"version-history":[{"count":0,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/217258\/revisions"}],"wp:attachment":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=217258"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=217258"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=217258"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}